Advertisement Novel technology in fixed-dose combinations – Unigel™: - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
close icon

Softigel by Procaps

Manufacturers of Softgel Pharmaceutical Products

More info about Softigel by Procaps

Novel technology in fixed-dose combinations – Unigel™:

Softigel by Procaps

Unigel™ (US Patent No. 8,967,989B2) is a first-to-market technology designed to combine multiple active pharmaceutical ingredient (API) formulations in one single soft gelatin capsule, offering multi-phase therapies, improving bioavailability, reducing manufacturing costs, and achieving superior adherence to different therapies.

Unigel™ (US Patent No. 8,967,989B2) is a first-to-market technology designed to combine multiple active pharmaceutical ingredient (API) formulations in one single soft gelatin capsule, offering multi-phase therapies, improving bioavailability, reducing manufacturing costs, and achieving superior adherence to different therapies.

Unigel™ technology provides various forms for fixed-dose combinations, such as a softgel in a softgel, a tablet in a softgel, granules in a softgel, or any combination to address challenges of multi-active formulation, offering unique prescription, over-the-counter (OTC) and OTX products.

Quick Contact Novel technology in fixed-dose combinations – Unigel™: